Gnosis, a Southern California-based diagnostic lab advancing women's health through molecular innovation, today announced the national launch of EdenDx, which stands for Early Detection for ...

Gnosis, a Southern California-based diagnostic lab advancing women's health through molecular innovation, today announced the national launch of EdenDx, which stands for Early Detection for ...

A pap smear or cervical screening isn’t the most exciting errand, but if you’ve been putting it off you may be in for a "completely different experience" than the last time you were tested.

Pramana, an AI-enabled health tech company modernizing the pathology sector, today announced it has received Health Canada Medical Device Licenses for its flagship digital pathology scanners, the ...

Cervical cancer is emerging as a serious public health concern in Kashmir, with cases steadily increasing in recent years. Once considered rare in the valley, it is now increasingly linked to ...

Gnosis has announced the launch of EdenDx, the first non-invasive, liquid-based cytology test for early endometrial cancer ...

The pap smear, which was introduced in the 1940s, made great inroads against the disease. Newer tests, such as a liquid-based cytology screen, have helped to improve the sensitivity of the testing ...

Artificial intelligence and high-performance computing are driving up the demand for massive sources of energy. But ...

Researchers have created a stable, hydrogen-rich liquid, making the clean fuel easier to store and release for everyday applications.

UChicago researchers have developed a new blood test that uses RNA modifications to detect early-stage colorectal cancer with 95% accuracy ...

A low-cost material made from clay—common in British soil—and vitamin B2 could one day help clean up pollution using only ...